Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive LY2216684 for SSRI partial responders with major depressive disorder
jRCT2080221401Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing LY2216684 + SSRI with Placebo + SSRI (2 arms). Started Mar 2011; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on jRCT2080221401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221401.